Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy … Read more
Market Cap & Net Worth: Pharmaron Beijing Co., Ltd. (PHBBF)
Pharmaron Beijing Co., Ltd. (PINK:PHBBF) has a market capitalization of $694.76 Million ($694.76 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #4549 globally and #2840 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmaron Beijing Co., Ltd.'s stock price $1.93 by its total outstanding shares 359977887 (359.98 Million).
Pharmaron Beijing Co., Ltd. Market Cap History: 2023 to 2025
Pharmaron Beijing Co., Ltd.'s market capitalization history from 2023 to 2025. Data shows growth from $707.21 Million to $694.76 Million (0.00% CAGR).
Pharmaron Beijing Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmaron Beijing Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Pharmaron Beijing Co., Ltd.'s market cap is 0.06 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.39x
Pharmaron Beijing Co., Ltd.'s market cap is 0.39 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $707.21 Million | $11.54 Billion | $1.60 Billion | 0.06x | 0.44x |
| 2024 | $694.76 Million | $12.28 Billion | $1.79 Billion | 0.06x | 0.39x |
Competitor Companies of PHBBF by Market Capitalization
Companies near Pharmaron Beijing Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Pharmaron Beijing Co., Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Pharmaron Beijing Co., Ltd. Historical Marketcap From 2023 to 2025
Between 2023 and today, Pharmaron Beijing Co., Ltd.'s market cap moved from $707.21 Million to $ 694.76 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $694.76 Million | 0.00% |
| 2024 | $694.76 Million | -1.76% |
| 2023 | $707.21 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharmaron Beijing Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $694.76 Million USD |
| MoneyControl | $694.76 Million USD |
| MarketWatch | $694.76 Million USD |
| marketcap.company | $694.76 Million USD |
| Reuters | $694.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.